Cargando…

Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingli, McClymont, Hannah, Warne, David J., Wang, Liping, Hu, Wenbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468375/
https://www.ncbi.nlm.nih.gov/pubmed/37663898
http://dx.doi.org/10.46234/ccdcw2023.139
_version_ 1785099226229768192
author Yang, Jingli
McClymont, Hannah
Warne, David J.
Wang, Liping
Hu, Wenbiao
author_facet Yang, Jingli
McClymont, Hannah
Warne, David J.
Wang, Liping
Hu, Wenbiao
author_sort Yang, Jingli
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination is heralded as the paramount solution to cease the pandemic, challenges persist in providing equitable access to COVID-19 vaccines. WHAT IS ADDED BY THIS REPORT? The distribution of vaccine coverage exhibited disparities between high-income and middle-income countries, with middle-income countries evidencing lower levels of vaccination. The data further suggested that countries with lesser vaccination levels tended to display a higher case fatality rate. Findings indicated that an increase in population-wide vaccination was effective in mitigating COVID-19 related mortalities. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The findings of this research underscore the pressing necessity for equitable access to vaccines to effectively mitigate the COVID-19 pandemic within the Asia-Pacific region.
format Online
Article
Text
id pubmed-10468375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-104683752023-09-01 Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 Yang, Jingli McClymont, Hannah Warne, David J. Wang, Liping Hu, Wenbiao China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination is heralded as the paramount solution to cease the pandemic, challenges persist in providing equitable access to COVID-19 vaccines. WHAT IS ADDED BY THIS REPORT? The distribution of vaccine coverage exhibited disparities between high-income and middle-income countries, with middle-income countries evidencing lower levels of vaccination. The data further suggested that countries with lesser vaccination levels tended to display a higher case fatality rate. Findings indicated that an increase in population-wide vaccination was effective in mitigating COVID-19 related mortalities. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The findings of this research underscore the pressing necessity for equitable access to vaccines to effectively mitigate the COVID-19 pandemic within the Asia-Pacific region. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023-08-18 /pmc/articles/PMC10468375/ /pubmed/37663898 http://dx.doi.org/10.46234/ccdcw2023.139 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Yang, Jingli
McClymont, Hannah
Warne, David J.
Wang, Liping
Hu, Wenbiao
Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title_full Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title_fullStr Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title_full_unstemmed Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title_short Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
title_sort comparative analysis of vaccine inequity and covid-19 transmission amid the omicron variant among countries — six countries, asia-pacific region, 2022
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468375/
https://www.ncbi.nlm.nih.gov/pubmed/37663898
http://dx.doi.org/10.46234/ccdcw2023.139
work_keys_str_mv AT yangjingli comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022
AT mcclymonthannah comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022
AT warnedavidj comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022
AT wangliping comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022
AT huwenbiao comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022